NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļNEO
āļāļ·āđāļāļāļĢāļīāļĐāļąāļNeogenomics Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 10, 2012
āļāļĩāļāļĩāđāļZook (Antony P)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ2200
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļDec 10
āļāļĩāđāļāļĒāļđāđ9490 Neogenomics Way
āđāļĄāļ·āļāļFORT MYERS
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ33912
āđāļāļĢāļĻāļąāļāļāđ12397680600
āđāļ§āđāļāđāļāļāđhttps://neogenomics.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļNEO
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 10, 2012
āļāļĩāļāļĩāđāļZook (Antony P)
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Dr. Neil Gunn
Independent Director
Ms. Felicia Williams
Independent Director
Mr. Antony P. Zook
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Gregory Aunan
Chief Accounting Officer
Ms. Marjorie C. Green
Independent Director
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
Dr. Alison L. Hannah, M.D.
Dr. Alison L. Hannah, M.D.
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Dr. Neil Gunn
Independent Director
Ms. Felicia Williams
Independent Director
Mr. Antony P. Zook
Chief Executive Officer, Director
Chief Executive Officer, Director
State Street SPDR S&P Health Care Services ETF
Invesco S&P SmallCap Health Care ETF
First Trust Nasdaq Lux Digi Health Solutions ETF
Inspire Small/Mid Cap ESG ETF
iShares U.S. Healthcare Providers ETF
Invesco S&P SmallCap 600 QVM Multi-factor ETF
iShares S&P Small-Cap 600 Value ETF
iShares ESG Select Screened S&P Small-Cap ETF
iShares Core S&P Small-Cap ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
State Street SPDR S&P Health Care Services ETF
āļŠāļąāļāļŠāđāļ§āļ2.38%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ0.77%
First Trust Nasdaq Lux Digi Health Solutions ETF
āļŠāļąāļāļŠāđāļ§āļ0.5%
Inspire Small/Mid Cap ESG ETF
āļŠāļąāļāļŠāđāļ§āļ0.32%
iShares U.S. Healthcare Providers ETF
āļŠāļąāļāļŠāđāļ§āļ0.2%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
āļŠāļąāļāļŠāđāļ§āļ0.14%
iShares S&P Small-Cap 600 Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.12%
Nuveen ESG Small-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.11%
iShares ESG Select Screened S&P Small-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.1%
iShares Core S&P Small-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.09%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ